StockData
XTLBNasdaqPharmaceutical Preparations

XTL BIOPHARMACEUTICALS LTD

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026
$1.96−0.00 (-0.01%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Xtl Biopharmaceuticals has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Xtl Biopharmaceuticals filed with the SEC